Vaccinations in patients with immunodeficiency or immunosuppressive therapy;Impfen bei Immundefekten oder medikamentöser Immunsuppression

Deutsche Medizinische Wochenschrift

Volumn 138, Issue 4, 2013, Pages 119-125

  Borso D ^a   Lobermann M ^a   Fritzsche, C ^a   Hemmer, C ^a   Fuhrer A ^a   Zettl, U ^a   Reisinger, E C ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

attenuated live vaccine; efficacy; Immunization; immunodeficiency; immunosuppression; inactivated vaccine; safety

Indexed keywords

INACTIVATED VACCINE;

ANTIBODY RESPONSE; ARTICLE; DISEASE SEVERITY; DRUG SAFETY; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; VACCINATION; REVIEW;

HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; IMMUNOSUPPRESSIVE AGENTS; INFECTION; VACCINATION;

EID: 84872492945     PISSN: 00120472     EISSN: 14394413     Source Type: Journal    
DOI: 10.1055/s-0032-1327401     Document Type: Article

References (53)

1. Anonymous. Measles immunization in HIV-infected children. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Pediatric AIDS. Pediatrics: 1999; 103 1057 1060
2. Anonymous. Passive Immunization. In: Pickering L. K., Baker C. J., Long S. S., McMillan J. A. Hrsg. Red Book: 2006 Report of the Committee on Infectious Diseases. 27. Aufl. Illinois American Academy of Pediatrics: 2006; 71 72
3. Anonymous. General recommendations on immunization - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep: 2011; 60 1 64
4. Beam T. R. Jr, Crigler E. D., Goldman J. K. et al. Antibody response to polyvalent pneumococcal polysaccharide vaccine in diabetics. JAMA: 1980; 244 2621 2624 (Pubitemid 11192750)
5. Bekker V., Westerlaken G. H., Scherpbier H. et al. Varicella vaccination in HIV-1-infected children after immune reconstitution. Aids: 2006; 20 2321 2329 (Pubitemid 44789534)
6. Bilukha O. O., Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep: 2005; 54 1 21
7. Borleffs J. C., Schneider M. M. Routine vaccination in HIV-infected patients: a review. Neth J Med: 1994; 45 244 249 (Pubitemid 24362329)
8. Brigden M. L. Detection, education and management of the asplenic or hyposplenic patient. Am Fam Physician: 2001; 63 499 506, 508 (Pubitemid 32165118)
9. Castro P., Plana M., Gonzalez R. et al. Influence of a vaccination schedule on viral load rebound and immune responses in successfully treated HIV-infected patients. AIDS Res Hum Retroviruses: 2009; 25 1249 1259
10. CDC Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep: 1993; 42 1 18
11. CDC Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep: 1997; 46 1 24
12. CDC Guidelines for Vaccinating Kidney Dialysis Patients and Patients with Chronic Kidney Disease. http://www.cdc.gov/vaccines/pubs/downloads/b-dialysis- guide-508.pdf verändert: 20.09.2010
13. CDC Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease. MMWR Morb Mortal Wkly Rep: 2009; 58 1042 1043
14. CDC Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Recomm Rep: 2001; 49 1 128
15. Chinen J., Shearer W. T. Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol: 2010; 125 195 203
16. Colquhoun A. J., Nicholson K. G., Botha J. L. et al. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes. Epidemiol Infect: 1997; 119 335 341 (Pubitemid 28025290)
17. Cornejo-Juarez P., Volkow-Fernandez P., Escobedo-Lopez K. et al. Randomized controlled trial of Hepatitis B virus vaccine in HIV-1-infected patients comparing two different doses. AIDS Res Ther: 2006; 3 9
18. Debat Zoguereh D., Ruiz J. M. [Immunosuppression and vaccinations]. Sante: 2000; 10 211 219
19. Duchini A., Goss J. A., Karpen S. et al. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev: 2003; 16 357 364 (Pubitemid 36871311)
20. Feuerhake A., Muller R., Lauchart W. et al. HBV-vaccination in recipients of kidney allografts. Vaccine: 1984; 2 255 256 (Pubitemid 15172281)
21. Fonseca M. O., Pang L. W., de Paula Cavalheiro N. et al. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine: 2005; 23 2902 2908 (Pubitemid 40386492)
22. Geretti A. M., Brook G., Cameron C. et al. British HIV Association guidelines for immunization of HIV-infected adults 2008. HIV Med: 2008; 9 795 848
23. Gluck T., Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis: 2008; 46 1459 1465 (Pubitemid 351589953)
24. Hilgendorf I., Freund M., Jilg W. et al. Vaccination of allogeneic haematopoietic stem cell transplant recipients: Report from the International Consensus Conference on Clinical Practice in chronic GVHD. Vaccine: 2011; 29 2825 2833
25. Hoffmann C., Rockstroh J. K. HIV 2010. Hamburg Medizin Fokus Verlag: 2010
26. Kapetanovic M. C., Saxne T., Nilsson J. A. et al. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford): 2007; 46 608 611 (Pubitemid 46523304)
27. Kroger A. T., Atkinson W. L., Marcuse E. K. et al. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep: 2006; 55 1 48
28. Kunisaki K. M., Janoff E. N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis: 2009; 9 493 504
29. Lederman M. M., Schiffman G., Rodman H. M. Pneumococcal immunization in adult diabetics. Diabetes: 1981; 30 119 121 (Pubitemid 11018678)
30. Lobermann M., Borso D., Hilgendorf I. et al. Immunization in the adult immunocompromised host. Autoimmun Rev: 2012; 11 212 218
31. Loebermann M., Winkelmann A., Reisinger E. C. et al. [Vaccination and multiple sclerosis]. Nervenarzt: 2010; 81 181 193
32. Looijmans-Van den Akker I., Verheij T. J., Buskens E. et al. Clinical effectiveness of first and repeat influenza vaccination in adult and elderly diabetic patients. Diabetes Care: 2006; 29 1771 1776 (Pubitemid 44156628)
33. Machado C. M. Reimmunization after bone marrow transplantation - current recommendations and perspectives. Braz J Med Biol Res: 2004; 37 151 158
34. McFarland E. Immunizations for the immunocompromised child. Pediatr Ann: 1999; 28 487 496
35. Melmed G. Y., Agarwal N., Frenck R. W. et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol: 2010; 105 148 154
36. Morath C., Arns W., Schwenger V. et al. Sirolimus in renal transplantation. Nephrol Dial Transplant: 2007; 22 08 viii61 viii65
37. Patel S. R., Ortin M., Cohen B. J. et al. Revaccination of children after completion of standard chemotherapy for acute leukemia. Clin Infect Dis: 2007; 44 635 642
38. Pozzilli P., Gale E. A., Visalli N. et al. The immune response to influenza vaccination in diabetic patients. Diabetologia: 1986; 29 850 854 (Pubitemid 17000996)
39. Rahier J. F., Moutschen M., Van Gompel A. et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford): 2010; 49 1815 1827
40. Rentenaar R. J., van Diepen F. N., Meijer R. T. et al. Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo. Kidney Int: 2002; 62 319 328 (Pubitemid 34754078)
41. Riley T. R. 3rd, Bhatti A. M. Preventive strategies in chronic liver disease: part II. Cirrhosis. Am Fam Physician: 2001; 64 1735 1740 (Pubitemid 33095869)
42. Rousseau M. C., Moreau J., Delmont J. Vaccination and HIV: a review of the literature. Vaccine: 1999; 18 825 831
43. Smith K. G., Isbel N. M., Catton M. G. et al. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant: 1998; 13 160 164 (Pubitemid 28033597)
44. STIKO Hinweise zu Impfungen für Patienten mit Immundefizienz. Epidemiol Bull: 2005; 39/2005 353 364
45. STIKO Stellungnahme zur Impfung Erwachsener gegen Pneumokokken. Epidemiol Bull: 2012; 7/2012 55 56
46. STIKO Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut/Stand: Juli 2012. Epidemiol Bull: 2012; 30/2012 283 310
47. Sung L., Heurter H., Zokvic K. M. et al. Practical vaccination guidelines for children with cancer. Paediatr Child Health: 2001; 6 379 383 (Pubitemid 32916580)
48. Suttorp M. Impfungen bei Kindern mit fehlender oder geschwächter Immunabwehr. Immunologie und Impfen: 1999; 2 70 76
49. Tomblyn M., Chiller T., Einsele H. et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant: 2009; 15 1143 1238
50. Urschel S., Cremer S., Birnbaum J. et al. Lack of serologic immunity against vaccine-preventable diseases in children after thoracic transplantation. Transpl Int: 2009; 23 619 627
51. van Assen S., Holvast A., Benne C. A. et al. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum: 2010; 62 75 81
52. van den Berg R., van Hoogstraten I., van Agtmael M. Non-responsiveness to hepatitis B vaccination in HIV seropositive patients; possible causes and solutions. AIDS Rev: 2009; 11 157 164
53. WHO Priority interventions: HIV/AIDS prevention, treatment and care in the health sector - 2010. Geneva WHO Press: 2010